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Background: A total of 750 000 cholecystectomies are performed annually in the USA. No data exist on
patients with microscopic high-grade dysplasia at the cystic duct margin and the associated incidence of
cholangiocarcinoma.
Methods: Pathology reports for 1992–2010 were reviewed for patients with high-grade dysplasia of the
cystic duct margin in the absence of invasive gallbladder cancer. Clinical data were obtained from chart
review.
Results: Five patients with high-grade dysplasia at the cystic duct margin without evidence of malig-
nancy were identified. Radiologic imaging was abnormal in two patients. The cystic duct stump was
abnormally dilated in both patients and one patient had an enlarged portacaval lymph node. All five
patients underwent exploration and resection of either the cystic duct stump or the bile duct. Specimens
in four of the patients showed no evidence of malignancy or dysplasia. One patient was found to have a
node-positive adenocarcinoma of the cystic duct.
Conclusions: High-grade dysplasia at the cystic duct margin without evidence of invasive gallbladder
cancer is rare. Patients with this finding should undergo cross-sectional imaging and a diagnosis of an
underlying cholangiocarcinoma should be considered, especially if imaging reveals any abnormalities.
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Introduction
Laparoscopic cholecystectomy is a common operation performed
worldwide. In the USA, approximately 750 000 cholecystectomies
are performed each year. Unsuspected gallbladder cancer is found
in 0.3–2.0% of cholecystectomy specimens.1–4 The finding of dys-
plasia in the absence of gallbladder cancer is uncommon, but its
true incidence is not well reported in the literature.5 The finding of
high-grade dysplasia at the cystic duct margin, without associated
gallbladder cancer, is therefore rare. Such a finding would raise an
obvious concern for an underlying carcinoma of the cystic duct or
an adenocarcinoma of the bile duct.
Bile duct cancers are frequently associated with dysplasia near
the primary tumour6–8 and can be multifocal in 10% of
patients.9–11 The majority of patients with multifocal disease have
a primary tumour in the bile duct and a second tumour in the
gallbladder.9,11 This raises the possibility that the finding of high-
grade dysplasia at the cystic duct margin may be associated with
an underlying bile duct carcinoma. The natural history of high-
grade dysplasia at the cystic duct margin, in the absence of known
gallbladder cancer, is unclear, and the optimum management of a
patient with this finding is unknown. The aim of this study was to
report a case series of five patients with this rare finding.
This paper is based on an oral presentation given at the 11th Annual Meeting
of the American Hepato-Pancreato-Biliary Association, 10–13 March 2011,
Miami, Florida.
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Materials and methods
With the approval of the local institutional review board (IRB),
a retrospective review of patients who presented with high-grade
dysplasia of the cystic duct in the absence of gallbladder cancer
was performed. A free text search of pathology reports for the
terms ‘cholecystectomy’, ‘cystic duct’ and ‘dysplasia’ was per-
formed; this identified 193 patients. Patients were included if
they had evidence of high-grade dysplasia at the cystic duct
margin. Patients were excluded if they had evidence of an inva-
sive cancer. Of the 193 patients initially identified, seven had
high-grade dysplasia at the cystic duct margin without evidence
of invasive cancer. Two of these patients had been evaluated by
our pathology department to provide second opinions on the
histologic diagnosis. As no follow-up data for these two patients
were available, they were excluded and thus the study included
five patients treated at the Memorial Sloan–Kettering Cancer
Center (MSKCC).
Patient, radiologic, pathologic and treatment-related variables
were obtained by retrospective chart review. Patient factors
evaluated included age, gender, medical comorbidities and
symptoms. Pre- and post-diagnosis imaging was reviewed.
Pathologic variables of the underlying malignancy (if present)
were recorded. Treatment-related variables included operative
and perioperative details and adjuvant therapy.
Results
Patient characteristics are summarized in Table 1. The majority of
the patients underwent imaging which consisted of magnetic
resonance imaging (MRI) with cholangiography. Radiologic
imaging was abnormal in two of the five patients. Both of these
patients had a dilated cystic duct and one had enlarged portal
nodes. In four of the five patients, surgical exploration revealed no
abnormalities and histologic evaluation demonstrated no evi-
dence of carcinoma or dysplasia. A bile duct adenocarcinoma was
found in one of the five patients. This patient was a 66-year-old
man who presented with nausea, vomiting and abdominal pain.
An ultrasound demonstrated sludge in the gallbladder and peric-
holecystic fluid. The patient underwent an uneventful laparo-
scopic cholecystectomy. Pathologic examination of the gallbladder
revealed focal areas of low- and high-grade dysplasia extending to
the cystic duct margin (Fig. 1). An MRI scan revealed a mildly
dilated cystic duct remnant with a slightly enlarged adjacent
lymph node (Fig. 2). The patient was explored and found to have
a palpable mass in the cystic duct remnant and metastases in
portal lymph nodes without evidence of distant metastases. He
underwent a bile duct resection, portal lymphadenectomy and
partial hepatectomy of segments IVb and V of the liver. Pathology
revealed a margin-negative T2N1 bile duct adenocarcinoma
centred at the cystic duct with four of six lymph nodes positive
Table 1 Patient characteristics
Patient 1 Patient 2 Patient 3 Patient 4 Patient 5
Age, years 66 77 61 65 57
Sex Male Female Male Male Female
Preoperative
imaging
MRCP PET/CT (non-contrast) MRCP Triphasic CT
MRCP
MRCP
ERCP
Radiographic
abnormality
Mildly dilated cystic
duct stump
Borderline enlarged
lymph node
No suspicious findings No suspicious findings Minimal thickening of
cystic stump
Sub-centimetre lesions
in segments III and IV
No suspicious
findings
Operation Bile duct resection
Portal
lymphadenectomy
Partial hepatectomy
segments IV and V
Cystic duct excision
Portal
lymphadenectomy
Partial hepatectomy
segments IV and V
Cystic duct excision
CBD exploration with
removal of stone
Bile duct resection
Portal
lymphadenectomy
Cystic duct
excision
Operative
findings
Palpable mass at cystic
duct remnant
Enlarged portal lymph
nodes
None CBD stone Palpable mass at cystic
duct remnant
No liver lesions
identified
None
Pathology Cholangiocarcinoma
(T2N1)
4/6 nodes positive
No evidence of
malignancy or
dysplasia
No evidence of
malignancy or
dysplasia
No evidence of
malignancy or
dysplasia
No evidence of
malignancy or
dysplasia
Status DoD: 15.3 months NED: 0.9 months NED: 16.0 months NED: 25.6 months NED: 2.1 months
MRCP, magnetic resonance cholangiopancreatography; PET, positron emission tomography; CT, computed tomography; ERCP, endoscopic retro-
grade cholangiopancreatography; CBD, common bile duct; DoD, died of disease; NED, no evidence of disease.
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(Fig. 3). The patient’s postoperative course was complicated by a
wound infection, but otherwise he recovered well. The patient was
treated with adjuvant gemcitabine, but subsequently suffered
disease recurrence and died of his disease 15 months after the date
of diagnosis.
Discussion
Dysplasia has been reported in cholecystectomy specimens in the
literature, but its true incidence is unknown.5 Little is known
about the incidence of dysplasia at the cystic duct margin. There
are no data on the incidence of cholangiocarcinoma or carcinoma
of the cystic duct in association with high-grade dysplasia at the
cystic duct margin of a cholecystectomy specimen. This small
series demonstrates that there is a small, but real, risk for under-
lying biliary carcinoma with this finding.
About 10% of bile duct carcinomas are multifocal,9–11 probably
as a result of either synchronous lesions or the intraepithelial
spread of tumour. It is therefore possible that high-grade dysplasia
at the cystic duct represents multifocal biliary neoplastic changes
or the extension of an underlying malignancy. Many bile duct
carcinomas involve the superficial spread of non-invasive cancer.
Sakamoto et al. found that 25% of resected hilar cholangiocarci-
nomas involved non-invasive extensions and that these extensions
might extend to 20 mm.12 Ebata et al. demonstrated that up to
50% of patients showed a superficial extension up to 1 mm and
11% presented with extensions up to 20 mm.13
The natural history of high-grade dysplasia of the cystic duct
margin in the absence of gallbladder carcinoma is unknown.
High-grade dysplasia, also known as carcinoma in situ or biliary
intraepithelial neoplasia grade 3 (BiliN3), is present at resected
margins of cholangiocarcinoma in 9–13% of patients.6–8 Survival
in these patients has been shown to be equivalent to that in
patients with negative surgical margins.6,7 This most probably
reflects the poor prognosis related to the invasive component in
these patients. However, one series found an increased rate of local
recurrence in longterm survivors with high-grade dysplasia at the
surgical margins.6 An earlier paper by Shirai et al. demonstrated
that two patients with early-stage gallbladder cancer and high-
grade dysplasia of the cystic duct developed local recurrence at >5
years after resection.14 Taken together, these findings suggest that
the progression of high-grade dysplasia to an invasive component
probably takes years.
The finding of high-grade dysplasia at the cystic duct margin in
the absence of associated gallbladder cancer is rare. A review of
pathology records at MSKCC demonstrated only seven patients
Figure 1 Pathology shows high-grade dysplasia of the cystic duct
margin in Patient 1. (Haematoxylin and eosin stain; original magni-
fication 100¥)
Figure 2 Magnetic resonance imaging in Patient 1 shows a dilated
cystic duct remnant (white arrow) and borderline enlarged lymph
node tissue (black arrow)
Figure 3 Pathology reveals invasive adenocarcinoma of the bile duct
wall in Patient 1. (Haematoxylin and eosin stain; original magnifica-
tion 100¥)
HPB 867
HPB 2011, 13, 865–868 © 2011 International Hepato-Pancreato-Biliary Association
who fit these criteria, and only five of them had been treated at
MSKCC. The small number of patients in this series makes it
difficult to draw conclusions. However, based on this series, it is the
authors’ recommendation that after review of pathology, patients
should undergo high-quality cross-sectional imaging to evaluate
the cystic duct remnant, the bile duct and locoregional lymph
nodes. Magnetic resonance cholangiopancreatography is an ideal
imaging modality in this context. Two of the five patients in this
series had abnormal imaging that revealed a dilated cystic duct
stump. The one patient with a carcinoma had a dilated cystic duct
as well as mildly enlarged portal lymph nodes. If imaging reveals
any abnormality, exploration with excision of the cystic duct
margin is recommended. Frozen-section analysis should be per-
formed and, if positive, complete resection to negative margins and
portal lymphadenectomy should be carried out. Given that one of
the five patients in this series was found to have a cholangiocarci-
noma, exploration and excision of the cystic duct stump should be
strongly considered, regardless of the findings on imaging.
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